Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy

Journal of Bone and Mineral Research

Volumn 13, Issue 5, 1998, Pages 891-899

  Thorén, Marja ^a   Hilding, Agneta ^a   Brismar, Torkel ^a   Magnusson, Per ^b   Degerblad, Marie ^a   Larsson, Lasse ^b   Sääf, Maria ^a   Baylink, David J ^c   Mohan, Subburaman ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c Jerry L Pettis Memorial VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; REGULATORY MECHANISM;

ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED;

EID: 0031966301     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.5.891     Document Type: Article

References (46)

1. Slootweg MC 1993 Growth hormone and bone. Horm Metab 25:335-343.
2. Elgindy N, Grunditz R, Thorén M, Degerblad M, Sjöberg HE, Ringertz H 1991 Longterm follow up of metacarpal cortical thickness and bone mineral density in panhypopituitarism. Radiol Diag (Berlin) 32:326-330.
3. De Boer H, Blok GJ, van Lingen A, Teule J, Lips P, Van der Veen EA 1994 The consequences of childhood onset growth hormone deficincy for adult bone mass. J Bone Miner Res 9:1319-1326.
4. Rosén T, Hansson T, Granhed H, Scucs J, Bengtsson BÅ 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:201-206.
5. Johansson AG, Burman P, Westermark K, Ljunghall S 1992 The bone mineral density in aquiered growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med 232:447-452.
6. Degerblad M, Bengtsson BÅ, Bramnert M, Johnell O, Manhem P, Rosén T, Thorén M 1995 Reduced bone mineral density in adults with growth hormone (GH) deficiency: Increased bone turnover during 12 months GH substitution therapy. Eur J Endocrinol 133:180-188.
7. Degerblad M, Hall K, Ringertz H, Sjöberg HE, Thorén M 1992 Potent effects of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenh) 128:397-404.
8. Johannsson G, Rosén T, Bosaeus I, Sjöström L, Bengtsson BA 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult onset GH deficiency. J Clin Endocrinol Metab 81:2865-2873.
9. Degerblad M, Bjellerup P, Brismar T, Thorén M 1996 Three years of growth hormone (GH) replacement therapy in adults-Increased and preserved bone mineral density. 10th International Congress of Endocrinology, pp. 3-47 (abstract).
10. Mohan S, Strong DD, Lempert VG, Tremollires F, Wergedal JE, Baylink DJ 1992 Studies on regulations of insulin-like growth factor binding protein (IGFBP)-S and IGFBP-4 production in human bone cells. Acta Endocrinol (Copenh) 127: 555-564.
11. Kassem M, Moseskilde L, Eriksen EF 1994 Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regul 4:131-135.
12. Nilsson A, Swolin D, Enerback S, Ohlsson C 1995 Expression of funtional growth hormone receptors in cultered human osteoblast-like cells. J Clin Endocrinol Metab 80:3483-3488.
13. Daughaday WH, Rotwein P 1989 Insulin-like growth factors I and II. Peptide messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 10:68-91.
14. Isgaard J, Nilsson A, Vikman K, Isaksson OG 1989 Growth hormone regulates the levels of insulin-like growth factor-I mRNA in rat skeletal muscle. J Endocrinol 120:107-112.
15. Mohan S, Baylink DJ 1991 Bone growth factors. Clin Orthop 263:30-48.
16. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DN, Rosenfeld RG 1996 Insulin-like growth factor binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619-637.
17. Mohan S, Baylink DJ 1996 Insulin-like growth factor (IGF)-binding proteins in serum - Do they have additional roles besides modulating the endocrine IGF actions? J Clin Endocrinol Metab 81:3817-3820.
18. Nicholas V, Mohan S, Honda Y, Prewett A, Finkelmann RD, Baylink DJ, Farley JR 1995 An age related decrease of insulin-like growth factor binding protein 5 in human cortical bone. Calcif Tissue Int 57:206-212.
19. Mohan S 1993 Insulin-like growth factor binding protein in bone cell regulation. Growth Regul 3:67-70.
20. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ 1995 Studies on mechanism by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270:20424-20431.
21. Rosen C, Donahue LR, Hunter S, Holich M, Kavookjian H, Kirschenbaum A, Mohan S, Baylink DJ 1992 The 24/25-kDa serum insulin-like growth factor binding protein is increased in elderly women with hip and spine fractures. J Clin Endocrinol Metab 74:24-27.
22. Jones JI, Clemmons DR 1995 Insulin-like growth factors and their binding proteins. Endocr Rev 16:3-34.
23. Kowarski A, Thompson RG, Migeon CJ, Blizzard RM 1971 Determination of integrated concentrations and true secretion rates of human growth hormone. J Clin Endocrinol Metab 32:356-360.
24. Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, Rosen T, Thorén M, Bengtsson BA 1996 The individual responsiveness to growth hormone (GH) treatment is dependent on the level of GH-binding protein, body mass index, age and gender. J Clin Endocrinol Metab 81:1575-1581.
25. Thorén M, Hilding A, Baxter RC, Wivall-Helleryd IL, Hall K 1997 Serum insulin-like growth factor (IGF), IGF binding protein (IGFBP)-1 and -3 and the acid labile subunit (ALS) as serum markers of body composition during growth hormone (GH) therapy in adults with growth hormone deficiency. J Clin Endocrinol Metab 82:223-228.
26. Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M 1997 Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. J Bone Miner Res 12:210-220.
27. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink DJ 1995 Development, validation and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab 80:2638-2645.
28. Honda Y, Landale EC, Strong DD, Baylink DJ, Mohan S 1996 Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids. J Clin Endocrinol Metab 81:1389-1396.
29. Bang P, Wivall IL, Eriksson U, Sara V, Hall K 1991 Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenh) 124:620-629.
30. Hilding A, Brismar K, Degerblad M, Thorén M, Hall K 1995 Altered relation between circulating levels of insulin-like growth factor binding protein-1 and insulin in growth hormone deficient patients and insulin dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 80:2646-2652.
31. Magnusson P, Löfman O, Larsson L 1992 Determination of alkaline phosphatase isoenzymes in serum by high performance liquid cromatography with post-column reaction detection. J Chromatogr 576:79-86.
32. Magnusson P, Löfman O, Larsson L 1993 Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphotase isoform analysis by high-performance liquid chromatography. Anal Biochem 211:156-163
33. Mazess RB, Barden HS, Bisek JP, Hansson J 1990 Dual energy x-ray absorptiometry for total body and regional bone mineral and soft tissue composition. Am J Clin Nutr 51:1106-1112.
34. Christiansen C, Rödbro P, Jensen H 1975 Bone mineral content in the forearm measured by photon absorptiometry. Scand J Clin Lab Invest 35:323-330.
35. Compstone JE, Evans WD, Crawly EO, Evans C 1988 Bone mineral content in normal UK subjects. Br J Radiol 61:631-636.
36. Ono T, Kanzaki S, Seino Y, Baylink DJ, Mohan S 1996 Growth hormone (GH) treatment of GH-deficient children increases serum levels of insulin-like growth factors (IGFs), IGF-binding protein -3 and -5, and bone alkaline phosphatase isoenzyme. J Clin Endocrinol Metab 81:2111-2116.
37. Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA 1997 Growth hormone (GH)-deficient men are more responsive to GH-replacement therapy than women. J Clin Endocrinol Metab 82:550-555.
38. Duan C, Hawes SB, Prevette T, Clemmons DR 1995 Insulinlike growth factor I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem 271:4280-4288.
39. Lempert UG, Bautista C, Strong DD, Baylink D, Mohan S 1991 Purification of a novel human bone derived insulin-like growth factor binding protein (hBP-IGFBP): A potential candidate for fixing IGF II in bone. J Bone Miner Res 6 (Suppl 1):5250.
40. McCarthy TL, Casinghino S, Centrella M, Canalis E 1994 Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures regulation by prostaglandin E2, growth hormone and the insulin-like growth factors. J Cell Physiol 160:163-175.
41. Slootweg MC, Ohlsson C, van Elk EJ, Netelenbos JC, Andress DL 1996 Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells. Growth Regul 6:238-246.
42. Bautista CM, Baylink DJ, Mohan S 1991 Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176:756-763.
43. Andress DL, Birnbaum RS 1992 Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem 267:22467-22472.
44. Mohan S, Farley JR, Baylink JD 1995 Age related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging. Progr Growth Factor Res 6:465-473.
45. Thorén M, Soop M, Degerblad M, Sääf M 1993 Preliminary study of the effects of growth hormone substitution therapy on bone mineral density and serum osteocalcin levels in adults with growth hormone deficiency. Acta Endocrinol (Copenh) 128 (Suppl 2):41-43.
46. Nicholas V, Prewett A, Bettica P, Mohan S, Finkelmann RD, Baylink DJ, Farley JR 1994 Age related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: Implications for bone loss with aging. J Clin Endocrinol Metab 78:1011-1016.